Semsa Gogcu, MD, MPH
- Clinical Associate Professor, Pediatrics

Semsa Gogcu, MD, MPH
- Education
- MD, Istanbul University Cerrahpasa - Turkey, 1996
- MPH, New York Medical College, 2016
- Residency
- Pediatrics, Albert Einstein College of Medicine Hospitals, 2010
- Fellowship
- Neonatology, Wake Forest University School of Medicine, 2008
- Board Certifications
- American Board of Pediatrics, Neonatal-Perinatal Medicine
- American Board of Pediatrics, Pediatrics
- Positions
- Clinical Associate Professor, Pediatrics
- Departments and Affiliations
- Pediatrics
Research
- Dexamethasone, Prednisolone, and Methylprednisolone Use and 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants. Puia-Dumitrescu M, Wood TR, Comstock BA, Law JB, German K, Perez KM, Gogcu S, Mayock DE, Heagerty PJ, Juul SE. JAMA Netw Open. 2022 Mar; 5(3):e221947.
- Deaths in a Modern Cohort of Extremely Preterm Infants From the Preterm Erythropoietin Neuroprotection Trial. Juul SE, Wood TR, Comstock BA, Perez K, Gogcu S, Puia-Dumitrescu M, Berkelhamer S, Heagerty PJ. JAMA Netw Open. 2022 02; 5(2):e2146404.
- Association between Term Equivalent Brain Magnetic Resonance Imaging and 2-Year Outcomes in Extremely Preterm Infants: A Report from the Preterm Erythropoietin Neuroprotection Trial Cohort. Mayock DE, Gogcu S, Puia-Dumitrescu M, Shaw DWW, Wright JN, Comstock BA, Heagerty PJ, Juul SE. J Pediatr. 2021 12; 239:117-125.e6.
- Intracranial Hemorrhage and 2-year Neurodevelopmental Outcomes in Extremely Preterm Infants. Law JB, Wood TR, Gogcu S, Comstock BA, Dighe M, Perez K, Puia-Dumitrescu M, Mayock DE, Heagerty PJ, Juul SE. J Pediatr. 2021 Jul;
- Assessment of 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants Receiving Opioids and Benzodiazepines. Puia-Dumitrescu M, Comstock BA, Li S, Heagerty PJ, Perez KM, Law JB, Wood TR, Gogcu S, Mayock DE, Juul SE. JAMA Netw Open. 2021 Jul; 4(7):e2115998.